Greater Glasgow and Clyde Medicines

Medicines Update

For all healthcare professionals across NHSGGC both in primary care and the acute sector.

Please note, Medicines Update blogs are correct at the time of publication.

Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact  medicines.update@ggc.scot.nhs.uk.

Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC resposnsible for the development of Medicines Update.

If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.

06/09/2023 announcement

Accessing GGC Clinical Guidelines via Medicines Update blogs and the Adult Therapeutics Handbook 

GGC Clinical Guidelines have migrated to the Right Decisions for Health and Care platform. As a result of the migration, direct links to GGC guidelines within Medicines Update blogs (and the Adult Therapeutics Handbook, GGC Medicines App) currently go to the homepage and not individual guidelines. This change was out with our control. 
Please note, there is a message on the homepage highlighting intermittent issues with the search function, therefore, if you cannot find a guideline via the search box, select the relevant category from the homepage or if the guideline still can't be found, contact clinical.guidelines@ggc.scot.nhs.uk. 
An update will be provided in due course.

Apremilast - New prescribing and supply arrangements

Posted: Friday, February 26, 2021

Category - Medicines Update

From February 2021, the maintenance dose of apremilast (one 30mg tablet twice daily) will be prescribed by the patient’s GP (one pack of 56 tablets per prescription). Specialist dermatology and rheumatology services will continue to prescribe the initial titration pack for new patients, and as before this will be dispensed in community pharmacies.

Read More...

Pico 7® dressing kit for use in post-op caesarean section incisional sites

Posted: Tuesday, February 23, 2021

Category - Medicines Update

Key messages

  • Pico 7® Single Use Negative Pressure Wound Therapy (sNPWT) dressing kit will be initiated on wound closure in theatre and will remain in situ for one week, under the ongoing care of acute midwives
  • When used for this indication, Pico 7® sNPWT kit or additional Pico 7® dressings should not be prescribed in Primary Care
  • Women will be provided with details of acute midwife and who to contact if a new dressing is required or for further advice on device
Read More...